Could Archer Aviation Stock Make You a Millionaire by 2036?

Archer Aviation shares are nearly 60% below last year, while its eVTOL business remains pre-commercialization and no eVTOLs are flying commercially in the U.S. Morgan Stanley projected the broader urban air mobility market could grow from $55 billion in 2030 to $1 trillion in 2040, but that estimate includes cargo and military markets and does not imply Archer will capture a large share. The article sees possible defense and autonomous-aircraft opportunities, but says Archer has substantial execution risks and may not become a millionaire-making investment without a successful air-taxi business.

Analysis

The investable question is not the size of the urban-air-mobility TAM; it is whether Archer can turn certification, manufacturing and route economics into repeatable cash flows before financing needs dilute the equity. A large forecast spanning passenger, cargo and defense does not establish Archer’s addressable revenue or share. The key second-order risk is capital and management allocation: defense work and the proposed Insitu acquisition could diversify demand, but could also consume execution bandwidth and manufacturing capacity without solving the passenger business’s certification and utilization hurdles. Boeing’s exposure should be assessed only against the actual transaction scope and terms; the article does not establish a material consolidated impact for BA.

Over the next several months, sentiment is likely to trade on verifiable certification progress, financing, customer commitments and acquisition details—not distant TAM estimates. Over 6–18 months, evidence of production readiness and economics per aircraft/route matters more than announcement volume. A reversal in certification timing, weaker funding access, or failure to demonstrate customer-backed deployment would undermine the equity case; successful milestones alone would not prove attractive returns without unit economics. Joby Aviation and established helicopter operators are relevant competitive checks, but this article provides no basis to rank their economics against Archer’s. Contrarian read: the market may be discounting the entire opportunity after a steep decline, yet a lower share price does not remove dilution or execution risk. No fundamental long is justified by the market forecast alone.

Key Decisions for Investors

• Do not buy ACHR on the TAM narrative or average down solely because the stock has fallen. Keep exposure, if any, sized as venture-like risk rather than a proven aerospace compounder.
• Treat ACHR as a milestone watch: revisit only after independently verifiable FAA certification progress, production-readiness evidence, and customer-backed deployment plans; require disclosure sufficient to assess funding runway and per-aircraft/route economics.
• Track the proposed Insitu transaction and Anduril relationship for deal terms, timing, and resource commitments. Do not infer a material BA earnings or valuation effect without evidence on transaction size and financial contribution.
• Falsification trigger for a constructive ACHR view: meaningful certification slippage, deteriorating access to capital, or repeated delays in converting announced partnerships into funded orders and operating deployments. Conversely, certification is necessary but not sufficient absent credible utilization and cash-flow evidence.